« Back to Record
Citation APA

Giuliani, R., Durbecq, V., Di Leo, A., Paesmans, M., Larsimont, D., Leroy, J.-Y., Borms, M., Vindevoghel, A., Jerusalem, G., D'Hondt, V., Dirix, L. Y., Canon, J.-L., Richard, V., Cocquyt, V., Majois, F., Reginster, M., Demol, J., Kains, J.-P., Delree, P., Keppens, C., Sotiriou, C., Piccart-Gebhart, M., & Cardoso, F. (2007). Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC). European journal of cancer, 43(4), 725-735. doi:10.1016/j.ejca.2006.11.019


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/54560

Giuliani, R., Durbecq, V., Di Leo, A., Paesmans, M., Larsimont, D., Leroy, J.-Y., Borms, M., Vindevoghel, A., Jerusalem, G., D'Hondt, V., Dirix, L. Y., Canon, J.-L., Richard, V., Cocquyt, V., Majois, F., Reginster, M., Demol, J., Kains, J.-P., Delree, P., Keppens, C., Sotiriou, C., Piccart-Gebhart, M., & Cardoso, F. (2007). Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC). European journal of cancer, 43(4), 725-735. doi:10.1016/j.ejca.2006.11.019